Transplant
October 9, 2024
Myeloma: Isa-KRd Induction Shows High MRD Responses
October 9, 2024
IMW: International Myeloma Workshop
MDedge Hematology and Oncology
October 3, 2024
Daratumumab Quadruplet Supported Transplant-Ineligible MM
October 3, 2024
IMW: International Myeloma Workshop
MDedge Hematology and Oncology
September 30, 2024
Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes
September 30, 2024
IMW: International Myeloma Workshop
MDedge Hematology and Oncology
September 18, 2024
First Combined Face and Eye Transplant Performed
September 18, 2024
MDedge Surgery